<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 06 Dec 2009 00:43:25 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>The Deep, Inner Meaning Of Bank of America's (BAC) TARP Repayment</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</guid>
      <description><![CDATA[As expected, Bank of America (BAC) will repurchase its $45 billion TARP preferreds, funded in part by an additional $18.8 billion in &quot;common stock equivalents&quot;, $4.0 billion in asset sales, and $1.7 billion in restricted stock issued to employees in lieu of cash bonuses.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3688027>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 14:19:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WFC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3688027</link>
    </item>
    <item>
      <title>Forget Yesterday, It's All About Jobs</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</guid>
      <description><![CDATA[Good morning. Stocks tanked in the last half-hour on Thursday and while the major news outlets attributed the decline to either profit taking or some trepidation in front of this morning's big Jobs report, we'd like to offer a little more substantial reason for the 85 point dive on an otherwise subdued day of trading.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3687896>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 13:21:30 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AKS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVLT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FSLR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPRO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRVL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NFLX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TXN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">V</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRSN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3687896</link>
    </item>
    <item>
      <title>Fed Balance Sheet Declines By $15 Billion After Improbable Reduction In MBS, Excess Reserves, Monetary Base Hit Record</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</guid>
      <description><![CDATA[The Federal Reserve's balance sheet declined by $15 billion to $2,183 billion from the prior week, after the Fed presumably offloaded $2.7 billion in MBS: this is the first time since QE started that MBS holdings have declined. If anyone can tell us just who the idiots are who bought MBS from the Fed (and at what price), and who the even greater idiots are who are supposed to believe this, please send us an email.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3686922>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 04:14:41 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">FNM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FRE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3686922</link>
    </item>
    <item>
      <title>China Will Continue To Drive The Global Economic Recovery In 2010</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</guid>
      <description><![CDATA[China isn’t just leading the global economic recovery – it’s lapping the field.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683989>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 14:38:07 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GROW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VALE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683989</link>
    </item>
    <item>
      <title>Interesting Stat: How Much Private Sector GDP Is From Construction And Real Estate?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</guid>
      <description><![CDATA[Back in June, we discussed commercial real estate at length following attendance at a large real estate conference in NYC. Our tone was cautious and one question we wondered about was the percentage of GDP that real estate represents. We actually came across the answer back in August and meant to share then, but didn't get to it. Since the question/topic remains highly relevant to considering the potential negative economic drag from depressed real estate activity, we're sharing now -- the following table is from an 8/28/09 NYTs article, &quot;Construction That Fueled Growth in the Sun Belt Slows&quot;:<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683785>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 13:15:56 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683785</link>
    </item>
    <item>
      <title>Credit Market Overview:  Dec 3, 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</guid>
      <description><![CDATA[The credit crunch crisis of confidence which we appear to be crawling out of even though the debt and equity markets catapulted themselves higher earlier this year could be similarly argued to be a crisis that started in the credit markets which crunched confidence around the world as it could a collapse in confidence in the value of the securities investors held which corrupted the credit markets causing them to cease funding.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3683773>[More...]</a>]]></description>
      <pubDate>Thu, 03 Dec 2009 12:59:02 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3683773</link>
    </item>
    <item>
      <title>Grab Some Northern Exposure With EWC</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</guid>
      <description><![CDATA[Emerging markets are captivating investors again, but tidy profits aren’t always far away. Placing your bets on well-established global markets can also prove rewarding. That's why we're looking at Canada.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3682040>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:39:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RIMM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3682040</link>
    </item>
    <item>
      <title>Unemployment Struggling To Turn A Corner As Job Losses Mount In November</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</guid>
      <description><![CDATA[U.S. job losses in the private sector slowed in November but still exceeded economists’ projections, a report by payroll-processing firm Automatic Data Processing (Nasdaq: ADP) indicated yesterday (Wednesday).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681965>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 21:20:20 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681965</link>
    </item>
    <item>
      <title>Why Barrick Closed Their Gold Hedge</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</guid>
      <description><![CDATA[It sure looks like gold is going to close above $1,200 an ounce today in New York. And large open market purchases from central banks in China, India and Russia are only helping the price surge more. (Just one year ago, some of these same central banks were actually selling gold in an attempt to fill an annual 10,000-ton supply gap.)<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3681409>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 19:15:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PAAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SSRI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3681409</link>
    </item>
    <item>
      <title>How To Profit From The 'Next' Dubai</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3679796</guid>
      <description><![CDATA[The Dubai World default is a matter of only $60 billion – mere peanuts when compared to other elements of the global financial crisis. It’s thus of concern only to those silly enough to invest in real estate there (and the European banks foolish enough to finance it.) For the rest of us, it is a useful reminder that sudden collapses don’t really come out of nowhere – they can be foreseen, and smart investors can plan for them.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3679796>[More...]</a>]]></description>
      <pubDate>Wed, 02 Dec 2009 13:51:42 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EBAY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3679796</link>
    </item>
    <item>
      <title>Business Highlights</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3689575</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Unexpected drop in jobless rate sparks optimism&lt;/li&gt;&lt;li&gt;WASHINGTON (AP) - A surprising drop in the unemployment rate and far fewer job losses last month raised hopes Friday for a sustained economic recovery.&lt;/li&gt;&lt;li&gt;The rate unexpectedly fell to 10 percent, from 10.2 percent in October, as employers cut the fewest number of jobs since the recession began.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3689575>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 22:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3689575</link>
    </item>
    <item>
      <title>Durect Q3 Net Loss Narrows</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3593397</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Durect, a US-based specialty pharmaceutical company, has reported a net loss of $5.54 million, or $0.07 per share, for the third quarter ended September 30, 2009, compared to a net loss of $9.16 million, or $0.11 per share, for the third quarter ended September 30, 2008.&lt;/li&gt;&lt;li&gt;Total revenues were $8.38 million for the third quarter of 2009, compared to $6.63 million for the same quarter of 2008. &lt;/li&gt;&lt;li&gt;Net loss for the nine months ended September 30, 2009 was $21.7 million, or $0.26 per share, compared to a net loss of $25.56 million, or $0.33 per share, for the nine months ended September 30, 2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3593397>[More...]</a>]]></description>
      <pubDate>Fri, 30 Oct 2009 13:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3593397</link>
    </item>
    <item>
      <title>City of Wichita to Fight Westar Rate Merger</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3393816</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Aug. 5--The city of Wichita will fight a proposed rate consolidation plan by Westar Energy that opponents say could eventually raise rates for south-central Kansas residents. &lt;/li&gt;&lt;li&gt;The KCC is scheduled to decide this fall whether to combine rates across the two divisions that make up Westar, the state's dominant utility, which has 675,000 customers. &lt;/li&gt;&lt;li&gt;Southern customers have traditionally paid higher rates than northern consumers because of high costs related to the Wolf Creek nuclear plant.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3393816>[More...]</a>]]></description>
      <pubDate>Wed, 05 Aug 2009 07:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WR</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3393816</link>
    </item>
    <item>
      <title>New York Hedge Fund Penalized for Not Disclosing Interests in Sale</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3370232</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Jul. 22--A New York hedge fund has agreed to pay $150,000 to settle  securities charges stemming from Mylan Inc.'s aborted $4 billion offer for a  rival drug company in 2004.  &lt;/li&gt;&lt;li&gt;The Securities and Exchange Commission yesterday charged Perry Corp. with  failing to disclose it held nearly 10 percent of Mylan shares as part of a  strategy to gain shareholder approval for the Cecil generic drug maker's  proposed acquisition of King Pharmaceuticals.  &lt;/li&gt;&lt;li&gt;Perry also held 7 million King shares that it stood to profit on if Mylan  shareholders approved the acquisition.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3370232>[More...]</a>]]></description>
      <pubDate>Wed, 22 Jul 2009 18:01:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MYL</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3370232</link>
    </item>
    <item>
      <title>Westar South Customers May Pay for North's Co2 Emissions</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3331673</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Jul. 5--If Congress passes legislation to reduce global-warming emissions, Westar Energy customers in northern Kansas could be on the hook for twice as much in rate increases as consumers in southern Kansas, analysts say. &lt;/li&gt;&lt;li&gt;That could become a key issue as the Kansas Corporation Commission ponders whether to equalize the rates for the two regions. &lt;/li&gt;&lt;li&gt;North and south have paid different rates since 1992, when Kansas Power &amp; Light merged with Kansas Gas &amp; Electric to form the company now known as Westar.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3331673>[More...]</a>]]></description>
      <pubDate>Sun, 05 Jul 2009 07:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WR</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3331673</link>
    </item>
    <item>
      <title>Stocks Tumble on Jobs News</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3330843</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Stocks got slammed in extremely light trading Thursday following the employment report, which revealed more weakness for job trends ahead of the long July 4 holiday weekend.&lt;/li&gt;&lt;li&gt;Action Economics said the report was weaker than expected due to a drop in the workweek to a new low of 33.0 hours from 33.1 over the last three months, and an associated big 0.8% drop in the hours-worked index. &lt;/li&gt;&lt;li&gt;Action Economics said it has revised down its second quarter GDP estimate to a decline of 2.5% from a drop of 2.0%.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3330843>[More...]</a>]]></description>
      <pubDate>Fri, 03 Jul 2009 14:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACUR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AIG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CAL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DAL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ELN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EXC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FSR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IPCR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LEA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LUV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NRG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SEPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VR</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3330843</link>
    </item>
    <item>
      <title>King Pharmaceuticals Reports Q1 Net Loss</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3231642</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;King Pharmaceuticals, a UK-based vertically integrated pharmaceutical company, has reported a net loss of $10.72 million, or $0.04 per diluted share, for the first quarter of 2009, compared to net earnings of $85.56 million, or $0.35 per diluted share, for the first quarter of 2008.&lt;/li&gt;&lt;li&gt;The company reported total revenues of $429.06 million for the first quarter ended March 31, 2009, compared to $432.03 million for the first quarter of 2008.&lt;/li&gt;&lt;li&gt;Joseph Squicciarino, King's CFO, said: &quot;During the first quarter, we substantially completed our integration initiatives associated with our December 2008 acquisition of Alpharma.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3231642>[More...]</a>]]></description>
      <pubDate>Thu, 14 May 2009 07:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3231642</link>
    </item>
    <item>
      <title>King Pharmaceuticals Posts $11M Loss</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3228468</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;May 12--King Pharmaceuticals officials are blaming an $11 million loss in the first quarter on increased competition for some of the company's most popular drugs and a one-time cost associated with its recent merger with Alpharma. &lt;/li&gt;&lt;li&gt;The company reported an $85.5 million gain during last year's first quarter, the reports state. &lt;/li&gt;&lt;li&gt;King CEO Brian Markison said the difference between the quarters is mostly due to a drop in revenue from the company's branded pharmaceuticals, like its blood pressure medication Altace, which had its first generic substitute in December 2007.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3228468>[More...]</a>]]></description>
      <pubDate>Tue, 12 May 2009 16:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3228468</link>
    </item>
    <item>
      <title>Three Contracts Show Praxair's Global Reach</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3223726</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;May 8--Danbury-based Praxair Inc. is growing internationally through deals with partners on two other continents. &lt;/li&gt;&lt;li&gt;Praxair (China) Investment Co. Ltd. has set up a joint venture in Guangzhou, China, with China Petroleum &amp; Chemical Corp. (Sinopec) and will become a supplier to Changhong Electric Co. Ltd., while Praxair Inc. has signed a marketing agreement with Nikolaus Sorg GmbH &amp; Co. KG, a subsidiary of The Sorg Group of Lohr am Main, Germany. &lt;/li&gt;&lt;li&gt;Praxair makes, sells and distributes industrial gases, as will its Chinese joint venture, Praxair-GPC Industrial Gases Co. Ltd. A major customer will be Sinopec Guangzhou, which will get its nitrogen supply from the venture, expected to start operations in the fourth quarter, according to David Chow, president of Praxair China.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3223726>[More...]</a>]]></description>
      <pubDate>Fri, 08 May 2009 09:51:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SNP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3223726</link>
    </item>
    <item>
      <title>King Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3634984</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to present at   the Lazard Capital Markets 6th Annual Healthcare Conference   on Wednesday, November 18, 2009, at 2:15 pm EST, at the St. Regis Hotel   in New York, New York. &lt;/li&gt;&lt;li&gt;The presentation may include a discussion of the   Company's marketed products, pipeline, strategy for growth, financial   results and expectations, and other matters relating to its business.&lt;/li&gt;&lt;li&gt;About King Pharmaceuticals, Inc.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3634984>[More...]</a>]]></description>
      <pubDate>Fri, 13 Nov 2009 20:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3634984</link>
    </item>
    <item>
      <title>King Pharmaceuticals to Present at Credit Suisse Healthcare Conference</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3613875</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a   live webcast of its presentation scheduled for Thursday, November 12,   2009, at 9:00 am Mountain Standard Time (11:00 am Eastern Standard   Time), at the Credit Suisse 2009 Healthcare Conference at the Arizona   Biltmore Hotel in Phoenix, Arizona. &lt;/li&gt;&lt;li&gt;The presentation may include a   discussion of the Company's marketed products, pipeline, strategy for   growth, financial results and expectations, and other matters relating   to its business.&lt;/li&gt;&lt;li&gt;About King Pharmaceuticals, Inc.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3613875>[More...]</a>]]></description>
      <pubDate>Fri, 06 Nov 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3613875</link>
    </item>
    <item>
      <title>King Pharmaceuticals to Present at UBS Global Life Sciences Conference</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3487571</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;King Pharmaceuticals, Inc. (NYSE:KG) today announced plans to provide a   live webcast of its presentation scheduled for Tuesday, September 22,   2009, at 11:00 a.m. ET, at the UBS Global Life Sciences Conference at   the Grand Hyatt Hotel in New York, New York. &lt;/li&gt;&lt;li&gt;The presentation may   include a discussion of the Company's marketed products, pipeline,   strategy for growth, financial results and expectations, and other   matters relating to its business. &lt;/li&gt;&lt;li&gt;About King Pharmaceuticals, Inc.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3487571>[More...]</a>]]></description>
      <pubDate>Thu, 17 Sep 2009 14:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3487571</link>
    </item>
    <item>
      <title>Acura Pharmaceuticals and King Pharmaceuticals Provide Update on Acurox&amp;#174; NDA</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3457442</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) and King Pharmaceuticals,   Inc. (NYSE: KG) announced today that they met with the U.S. Food and   Drug Administration (&quot;FDA&quot;) on September 2, 2009 to discuss the FDA's   June 30, 2009 Complete Response Letter regarding the New Drug   Application for Acurox&amp;#174; (oxycodone HCl and niacin)   Tablets CII (NDA). &lt;/li&gt;&lt;li&gt;The FDA and the Companies agreed to take the NDA to   an FDA Advisory Committee to consider the evidence to support the   potential opioid abuse deterrent effects of Acurox&amp;#174;   Tablets. &lt;/li&gt;&lt;li&gt;The FDA indicated that no new clinical trials are required at   this time.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3457442>[More...]</a>]]></description>
      <pubDate>Thu, 03 Sep 2009 21:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACUR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3457442</link>
    </item>
    <item>
      <title>BenchmarkJournal.Com Free Analyst Review for ANN, GGB, KG, PFG, IAG and QTM</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3448920</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Benchmark Journal brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear picture of investment opportunities. &lt;/li&gt;&lt;li&gt;Today we began research on AnnTaylor Stores Corp. (NYSE: ANN), Gerdau S.A. (NYSE: GGB), King Pharmaceuticals Inc. (NYSE: KG), Principal Financial Group Inc. (NYSE: PFG), IAMGOLD Corp. (NYSE: IAG) and Quantum Corp. (NYSE: QTM).&lt;/li&gt;&lt;li&gt;To view our research, sign up now and get started with your complimentary subscription.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3448920>[More...]</a>]]></description>
      <pubDate>Tue, 01 Sep 2009 12:07:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ANN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GGB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IAG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">QTM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3448920</link>
    </item>
    <item>
      <title>DURECT Signs Long Term Excipient Supply Agreement With King Pharmaceuticals for REMOXY(R)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3443147</guid>
      <description><![CDATA[DURECT Corporation today reported that it has signed an exclusive long term excipient supply agreement with respect to REMOXY with King Pharmaceuticals, Inc. . This agreement stipulates the terms and conditions under which DURECT will supply to King, based on DURECT's manufacturing cost plus a specified percentage mark-up, two key excipients used in the manufacture of REMOXY.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3443147>[More...]</a>]]></description>
      <pubDate>Thu, 27 Aug 2009 11:56:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">DRRX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3443147</link>
    </item>
    <item>
      <title>Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3417518</guid>
      <description><![CDATA[King Pharmaceuticals), Inc. today announced that the U.S. Food and Drug Administration has approved EMBEDA Extended Release Capsules for oral use, a long-acting Schedule II opioid analgesic for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. EMBEDA is the first FDA-approved long-acting opioid that is designed to reduce drug liking and euphoria when tampered with by crushing or chewing.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3417518>[More...]</a>]]></description>
      <pubDate>Thu, 13 Aug 2009 19:55:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3417518</link>
    </item>
    <item>
      <title>King Pharmaceuticals Reports Second Quarter 2009 Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3397845</guid>
      <description><![CDATA[King Pharmaceuticals, Inc. (NYSE:KG) announced today that total revenues were $445 million during the second quarter ended June 30, 2009, compared to $397 million in the second quarter of 2008. The Company reported a net income of $38 million and diluted earnings per share of $0.15 during the second quarter of 2009, compared to net income of $41 million and diluted earnings per share of $0.17 in the second quarter of the prior year. Excluding certain special items and recurring non-GAAP adjustments, adjusted net income equaled $80 million and adjusted diluted earnings per share equaled $0.32 during the second quarter ended June 30, 2009, compared to adjusted net income of $87 million and adjusted diluted earnings per share of $0.35 in the second quarter of 2008.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3397845>[More...]</a>]]></description>
      <pubDate>Thu, 06 Aug 2009 11:03:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3397845</link>
    </item>
    <item>
      <title>Pain Therapeutics Reviews Mid-Year Progress, Reports Second Quarter 2009 Financial Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3390716</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Hemophilia and Melanoma Data Expected by Year End -&lt;/li&gt;&lt;li&gt;SAN MATEO, Calif., Aug. 4, 2009 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today reviewed mid-year progress with its drug candidates and reported financial results for the quarter ended June 30, 2009.&lt;/li&gt;&lt;li&gt;&quot;By year end 2009, we expect to announce top-line results from on-going studies with our drug candidates in two important disease areas - hemophilia and melanoma.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3390716>[More...]</a>]]></description>
      <pubDate>Tue, 04 Aug 2009 13:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PTIE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3390716</link>
    </item>
    <item>
      <title>Ligand Pharmaceuticals Announces Second Quarter Results</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3389112</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Total revenues from continuing operations for the three months ended   June 30, 2009 were $7.6 million, compared with $4.8 million for the same   period in 2008. &lt;/li&gt;&lt;li&gt;Operating costs and expenses from continuing operations in the second   quarter of 2009 were $12.7 million, compared with $10.9 million in the   second quarter of 2008. &lt;/li&gt;&lt;li&gt;Total revenues for the six months ended June 30, 2009, were $17.1   million, compared with $9.7 million for the first six months of 2008.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3389112>[More...]</a>]]></description>
      <pubDate>Mon, 03 Aug 2009 20:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LGND</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3389112</link>
    </item>
    <item>
      <title>Form  4          KING PHARMACEUTICALS      For: Nov 16  Filed by: BROUILLETTE FREDERICK JR (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3644293</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3644293>[More...]</a>]]></description>
      <pubDate>Tue, 17 Nov 2009 21:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3644293</link>
    </item>
    <item>
      <title>Form  4          BROUILLETTE FREDERICK     For: Aug 13 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3415367</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3415367>[More...]</a>]]></description>
      <pubDate>Fri, 14 Aug 2009 22:33:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3415367</link>
    </item>
    <item>
      <title>Form  4          BROUILLETTE FREDERICK     For: Jun 08 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3263713</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3263713>[More...]</a>]]></description>
      <pubDate>Tue, 09 Jun 2009 22:30:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3263713</link>
    </item>
    <item>
      <title>Form  4          MOYER CHARLES             For: Jun 01 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3254563</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3254563>[More...]</a>]]></description>
      <pubDate>Tue, 02 Jun 2009 22:29:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3254563</link>
    </item>
    <item>
      <title>Form  4          Carter Eric G             For: Mar 23 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3148251</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3148251>[More...]</a>]]></description>
      <pubDate>Wed, 25 Mar 2009 22:44:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3148251</link>
    </item>
    <item>
      <title>Form  4          MARKISON BRIAN A          For: Mar 23 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3148245</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3148245>[More...]</a>]]></description>
      <pubDate>Wed, 25 Mar 2009 22:43:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3148245</link>
    </item>
    <item>
      <title>Form  4          Elrod James W             For: Mar 23 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3148247</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3148247>[More...]</a>]]></description>
      <pubDate>Wed, 25 Mar 2009 22:43:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3148247</link>
    </item>
    <item>
      <title>Form  4          Squicciarino Joseph       For: Mar 20 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3144675</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3144675>[More...]</a>]]></description>
      <pubDate>Tue, 24 Mar 2009 22:40:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3144675</link>
    </item>
    <item>
      <title>Form  4          MARKISON BRIAN A          For: Mar 20 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3144671</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3144671>[More...]</a>]]></description>
      <pubDate>Tue, 24 Mar 2009 22:39:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3144671</link>
    </item>
    <item>
      <title>Form  4          GREEN JAMES E             For: Mar 20 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3144673</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3144673>[More...]</a>]]></description>
      <pubDate>Tue, 24 Mar 2009 22:39:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3144673</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=ALO,KG," rel="self" type="application/rss+xml" />
  </channel>
</rss>